APEX
Research Project |
|
A phase 2 open-label, multicenter clinical study of the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib as a single agent in patients with advanced systemic mastocytosis
A phase 2 open-label, multicenter clinical study of the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib as a single agent in patients with advanced systemic mastocytosis